Obbligazioni in dollari Keep Calm And Invest Preferred Shares Usa
Joe Silver
Forumer storico
Visto che è natale , per scherzo ho messo in vendita 50 pezzi a 25,9 ..............eseguito !O sono io che mi perdo qualche cosa ????
Prezzi mai visti
Fabrib
Forumer storico
I "nostri ragazzi" lavorano anche a Natale!Visto che è natale , per scherzo ho messo in vendita 50 pezzi a 25,9 ..............eseguito !
British Airways cabin crew have called off a planned Christmas strike, trade union Unite said on Thursday.
Unite said the decision was made after it received a revised offer from British Airways. The offer will be put to a ballot of its members.
The planned cabin crew strike on Boxing Day has also been suspended, Unite general secretary Len McCluskey said in a statement.
British Airways said it welcomed the announcement.
Thousands of cabin crew members working for British Airways had voted on Dec. 16 in favour of strike action in a pay dispute. Unite had earlier said that over 2,500 Unite members who crew long- and short-haul routes to dozens of destinations were to walk out after Dec. 21.
A number of planned strikes have been called this month. Among these are walkouts by airline cabin staff, baggage handlers, rail conductors and Post Office counter workers.
UK Prime Minister Theresa May had criticised the wave of strikes sweeping Britain as unacceptable action that showed "contempt" for ordinary people in the run-up to Christmas.
(Reporting by Sangameswaran S in Bengaluru; Editing by John Stonestreet and James Dalgleish
Joe Silver
Forumer storico
Come si dice(va) a Milano: lavùra, lavùra...
Fabrib
Forumer storico
Saratoga Investment (NYSE
AR), a smaller sized BDC, with assets under management of just $272 million, has sold a new baby bond issue in a refinancing transaction. The new bond has a coupon of 6.75% and a maturity date of 12/30/2023 making it a relatively short duration security.
The new issue from Saratoga is $65 million in size and the company has stated the intention to call their SAQ issue with the proceeds. The SAQ issue has a coupon of 7.50% and became initially callable on 5/31/2016. The issue being called was a $42 million issue so the new issue will readily cover the cost of bringing in the old issue, leaving the balance for general corporate purposes.
The new issue ticker symbol is SAB and there will be no OTC Grey Market trading since it is a debt issue and debt issues do not trade on the OTC prior to permanent market trading.
We note that we hold the 7.50% Saratoga baby bonds in all of the model portfolios and in addition we hold shares in our personal accounts. The issue has provided a nice, non volatile, 7.50% income stream for quite a few years and we are sorry to see it go. Now we will need to find a spot to redeploy the proceeds from call. It is very likely that we will go ahead and buy the new issue for our Short/Medium Duration Income Portfolio as well as the Moderate Duration Income with Zip Portfolio. Even though the new issue has a coupon of just 6.75% with a maturity date of 2023 it fits the requirements of these 2 portfolios and swapping a new 6.75% for the old 7.50% is not significant damage to the income flow.
Details of this new issue can be found here. We expect this issue to begin trading in the next couple of days.
To get more information on preferred stocks and exchange traded debt (baby bonds), screen them, set up your own portfolio and receive email alerts, go to www.preferred-stock.com now.
AR), a smaller sized BDC, with assets under management of just $272 million, has sold a new baby bond issue in a refinancing transaction. The new bond has a coupon of 6.75% and a maturity date of 12/30/2023 making it a relatively short duration security.The new issue from Saratoga is $65 million in size and the company has stated the intention to call their SAQ issue with the proceeds. The SAQ issue has a coupon of 7.50% and became initially callable on 5/31/2016. The issue being called was a $42 million issue so the new issue will readily cover the cost of bringing in the old issue, leaving the balance for general corporate purposes.
The new issue ticker symbol is SAB and there will be no OTC Grey Market trading since it is a debt issue and debt issues do not trade on the OTC prior to permanent market trading.
We note that we hold the 7.50% Saratoga baby bonds in all of the model portfolios and in addition we hold shares in our personal accounts. The issue has provided a nice, non volatile, 7.50% income stream for quite a few years and we are sorry to see it go. Now we will need to find a spot to redeploy the proceeds from call. It is very likely that we will go ahead and buy the new issue for our Short/Medium Duration Income Portfolio as well as the Moderate Duration Income with Zip Portfolio. Even though the new issue has a coupon of just 6.75% with a maturity date of 2023 it fits the requirements of these 2 portfolios and swapping a new 6.75% for the old 7.50% is not significant damage to the income flow.
Details of this new issue can be found here. We expect this issue to begin trading in the next couple of days.
To get more information on preferred stocks and exchange traded debt (baby bonds), screen them, set up your own portfolio and receive email alerts, go to www.preferred-stock.com now.
NoWay
It's time to play the game
Tra le emissioni recenti c'è anche questa...
Rennova Health, Inc. — Preferred Stock Offering
Company: Rennova Health, Inc. (NASDAQ:RNVA)
Date announced: 12/16/2016
Shares Offered: 12,350
Date of Pricing: 12/16/2016
Price Per Share: $1,000
Preferred Stock Offering Details: Rennova Health, Inc. (NASDAQ: RNVA) today announced the pricing of an underwritten public offering of 12,350 shares of its Series H Convertible Preferred Stock at a per share price to the public of $1,000. The Series H Preferred Stock has a stated value of $1,000 per share with each share convertible into 11,111 shares of common stock, at a conversion price of $0.09 per share. The gross proceeds to Rennova Health, Inc. from this offering are expected to be approximately $12,350,000 before deducting underwriting discounts and commissions and other estimated offering expenses. Approximately $8,300,000 of the net proceeds from this offering will be used to redeem certain outstanding shares of Rennova Health's Series G Convertible Preferred Stock. The offering is expected to close on December 20, 2016, subject to customary closing conditions.
Rennova Health is a provider of diagnostics and supportive software solutions to healthcare providers. Co. delivers products and services including laboratory diagnostics, healthcare technology solutions, and revenue cycle management, to medical providers. Co.'s principal line of business is clinical laboratory blood and urine testing services, with a focus on the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities. Co. also has genetic testing, specifically pharmacogenetic testing. Co. operates in three segments: clinical laboratory operations, supportive software solutions and decision support and informatics operations.
Rennova Health, Inc. — Preferred Stock Offering
Company: Rennova Health, Inc. (NASDAQ:RNVA)
Date announced: 12/16/2016
Shares Offered: 12,350
Date of Pricing: 12/16/2016
Price Per Share: $1,000
Preferred Stock Offering Details: Rennova Health, Inc. (NASDAQ: RNVA) today announced the pricing of an underwritten public offering of 12,350 shares of its Series H Convertible Preferred Stock at a per share price to the public of $1,000. The Series H Preferred Stock has a stated value of $1,000 per share with each share convertible into 11,111 shares of common stock, at a conversion price of $0.09 per share. The gross proceeds to Rennova Health, Inc. from this offering are expected to be approximately $12,350,000 before deducting underwriting discounts and commissions and other estimated offering expenses. Approximately $8,300,000 of the net proceeds from this offering will be used to redeem certain outstanding shares of Rennova Health's Series G Convertible Preferred Stock. The offering is expected to close on December 20, 2016, subject to customary closing conditions.
Rennova Health is a provider of diagnostics and supportive software solutions to healthcare providers. Co. delivers products and services including laboratory diagnostics, healthcare technology solutions, and revenue cycle management, to medical providers. Co.'s principal line of business is clinical laboratory blood and urine testing services, with a focus on the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities. Co. also has genetic testing, specifically pharmacogenetic testing. Co. operates in three segments: clinical laboratory operations, supportive software solutions and decision support and informatics operations.
Trans77
Si vis pacem, para bellum
Ciao Fabrib, conosco poco l'emittente ma cedola e prezzo sembrano allettanti...situazione della società com'è, nella media dei competitors?
Non so se è solo una coincidenza, in effetti su Binck l'ho trovata normalmente, ma su Dividend mi è uscita sta schermata:
Fabrib
Forumer storico
Ciao Trans, di seguito alcuni dati.
La società:
MarketWatch.com Mobile
La preferred:
MarketWatch.com Mobile
S&P Rating NR Moodys Rating NR
Security Ticker Symbol MITT-A
Market Traded ON NYSE
Dividend Payment Paid on the 17th of March, June, September and December beginning on 09/17/2012
Quarterly Dividend .516 Annual Dividend 2.063
Securities may be redeemed, at the issuers option, as early as 08/03/2017 the call price is $25 plus accrued dividends
Dividend Payment NOT will be Qualified Distributions
Maturity Date None
Company Investor Relations Page for AG Mortgage Investment
La società:
MarketWatch.com Mobile
La preferred:
MarketWatch.com Mobile
S&P Rating NR Moodys Rating NR
Security Ticker Symbol MITT-A
Market Traded ON NYSE
Dividend Payment Paid on the 17th of March, June, September and December beginning on 09/17/2012
Quarterly Dividend .516 Annual Dividend 2.063
Securities may be redeemed, at the issuers option, as early as 08/03/2017 the call price is $25 plus accrued dividends
Dividend Payment NOT will be Qualified Distributions
Maturity Date None
Company Investor Relations Page for AG Mortgage Investment
Trans77
Si vis pacem, para bellum
Grazie Fabrib, stavo appunto iniziando a dare un'occhiata, di scheletri nell'armadio non ne ho trovati, campanelli d'allarme non mi sono suonati (tutto relativo, nel senso che parliamo di una società che capitalizza nemmeno mezzo miliardo), potrei girarci le DB 8,05 che credo di vendere oggi.
Guardavo un pò di emittenti che avevo iniziato a catalogare su un foglio elettronico mesi fa, mi devo essere perso qualcosa: sia
American Cap Mtge 8,125% che American Capital Agency 7.75% non li trovo più negoziabili su Binck, nonostante la call sia nel 2019: sapete che è successo? Grazie.
Fabrib
Forumer storico
Se
Sort Preferred Stocks Alphabetically | The Yield Hunter
Se non mi confondo la prima dovrebbe essere stata richiamata, la seconda invece risulta a mercato, ma come dici tu, su Binck non si trova.
Sort Preferred Stocks Alphabetically | The Yield Hunter